Frontlight ResearchEarly access
Not yet recruitingNo phase
Prospective, Multi-Center Observational Registry of Melanoma CP-GEP and Clinical Outcomes
Key facts
- Who runs it
- SkylineDx
- Trial code
- Status
- Not yet recruiting
- People taking part
- 2,000 people, planned
- Starts
- Jan 2027
- Expected to end
- Jan 2032
- Type of study
- Observational
- Record updated
- 13 November 2026
Who can take part
- Age
- 65 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Newly diagnosed invasive malignant melanoma of the skin (AJCC 8th edition staging guidelines)
- pT1-pT4 cN0M0
- Male or female, age ≥65 years
- Merlin CP-GEP testing performed, and a valid result obtained
- Ability to provide informed consent, or availability of a legally authorized representative when permitted by applicable law and institutional policy
Who cannot take part
- Documented history of another (prior or concurrent) primary invasive melanoma of T1a or greater at any site in their lifetime
- Previous surgery or radiation therapy to the draining lymph node basin(s) of the current primary melanoma
- Distant metastatic disease (M1a, M1b, M1c, or M1d) clinically present at primary diagnosis
- Ocular, vulvar, perianal, or mucosal melanomas, or melanocytic tumors of uncertain malignant potential (MELTUMP) or atypical Spitz tumors
- Documented clinically apparent nodal metastases at diagnosis
About the trial
What the trial wants to find out
The purpose of the registry is to understand how Merlin CP-GEP testing is used in routine care and whether the test result is associated with clinical decision-making in people with melanoma who are 65 years of age or older. The study will also collect available information about treatment decisions and clinical outcomes over time.
The group in the trial
- Newly diagnosed primary cutaneous melanoma patients
Newly diagnosed primary cutaneous melanoma patients, 65 years of age and older, with a valid Merlin CP-GEP result.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Merlin CP-GEP Prospective Clinical Registry
- Record updated
- 13 November 2026